FedEx: BMO Raises Target To $315 Following Financial Results

FedEx Corp (NYSE: FDX) reported their fiscal fourth-quarter earnings on June 24 after hours. The company announced that revenue came in at $22.56 billion for the quarter, up from $17.36 billion a year ago. The company reported 71% gross margins with an operating margin of 8%. The firm also reported a net income of $1.87 billion, or $6.88 earnings per share.

For the full year, revenues came in at $84 billion and they had a $5.23 billion net income or a $19.45 earnings per share. The company guided earnings per share for 2022 to come in between $18.90 to $19.90.

A few analysts upgraded their 12-month price target on FedEx after the results, bringing the consensus price target to $343.88, up from $333.24. There are 32 analysts covering the stock. Out of the 32, ten analysts have strong buy ratings, 15 have buy ratings, six have hold ratings and a single analyst has a strong sell rating. The street high comes from Loop Capital with a $381 price target and the lowest sits at $198.

In BMO’s note to investors, their analyst Fadi Chamoun says that the results were decent but the outlook, “falls short of delivering a bull case.” FedEx’s stock ended the Friday session down almost 4%.

Chamoun says that the fourth-quarter results came in strong “across all three operating segments.” Adjusted EBIT came in 1% higher than their estimate, while the beat came from the Ground and Freight segments. For the specific segments, Express came in 2.2% above expectations, ADV rose 20.3%, international export was up 31.1%, and U.S packages increased 22.6%. The ground ADV segment rose 14.4% due to a recovery in business-to-business packages.

While Chamoun only has a few things to say about the 2022 guidance, he does that that they are “largely better than anticipated, albeit we sense that they did not meet the bull case framework.” The latter is specifically related to the CAPEX and higher ROIC due to labor cost inflation and not being able to time larger contract renewals. The company guided for a 13-18% earnings per share growth in 2022.

Below you can see BMO’s updated 2022/2023 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why Silver Needs to Slow Down to Go Higher | Dan Dickson – Endeavour Silver

Silver Dips Are Getting Bought, This Is How Breakouts Start | John Feneck

Why $100 Silver Right Now Would Be a Problem | Keith Neumeyer – First Majestic

Recommended

Antimony Resources Drills 8.48% Sb Over 3 Metres, 2.07% Sb Over 27 Metres At Bald Hill

Steadright To Acquire 75% Interest In Moroccan Copper-Lead-Silver Project

Related News

BMO Cuts Roger Communications’ Price Target After Boardroom Drama Flares Up

On October 8th, The Globe and Mail reported on the recent and abrupt departure of...

Sunday, October 17, 2021, 01:07:00 PM

Canaccord: Uranium Fundamentals Remain Robust

On February 2nd, Canaccord Genuity Capital Markets’ put out a note on the uranium sector....

Sunday, February 6, 2022, 03:17:00 PM

Canopy Growth Sees Cantor Lower Price Target To $21

Last week, Cantor Fitzgerald updated their estimates on a bundle of Canadian licensed producers. In...

Friday, September 24, 2021, 03:33:00 PM

Canaccord Genuity Raises Medipharm Labs’ Price Target To C$2.50

On Monday Medipharm Labs (TSX: LABS) announced an exclusive medical cannabis partnership with the European...

Tuesday, October 6, 2020, 01:29:18 PM

Curaleaf: Cormark Upgrades To Buy Rating, Canaccord, Haywood Raise Price Targets

After Curaleaf’s (CSE: CURA) record-breaking second-quarter numbers, analysts have upgraded their twelve-month price targets. Curaleaf...

Wednesday, August 19, 2020, 11:29:55 AM